Profiel
Andrew McNeill is an Investor Director at Cumulus Oncology Ltd. He is also an Investor Director at Dxcover Ltd. and a Managing Partner at EOS Syndicate Management Ltd. Previously, he served as the Chairman of Chromacity Ltd. from 2017 to 2019.
Mr. McNeill completed his undergraduate degree at the University of Leeds in 2003.
Actieve functies van Andrew McNeill
| Bedrijven | Functie | Begin |
|---|---|---|
EOS Syndicate Management Ltd.
EOS Syndicate Management Ltd. Investment ManagersFinance EOS Syndicate Management invests in companies located in United Kingdom. The firm targets companies operating in science, engineering and technology sector. It provides financing for seed and growth stage capital requirements with an investment size ranging from EUR 0.1 - 1 millions. It also makes co-investment. | Private Equity Investor | 01-11-2017 |
Cumulus Oncology Ltd.
Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Directeur van Onderzoek - Eigen Vermogen | - |
Dxcover Ltd.
Dxcover Ltd. Medical SpecialtiesHealth Technology Manufactures hardware and develops artificial intelligence based software for early detection of cancers | Private Equity Investor | 01-03-2019 |
Eerdere bekende functies van Andrew McNeill
| Bedrijven | Functie | Einde |
|---|---|---|
Chromacity Ltd.
Chromacity Ltd. Medical SpecialtiesHealth Technology Designs, manufactures and supplies ultrafast fibre lasers | Voorzitter | 01-11-2019 |
Opleiding van Andrew McNeill
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EOS Syndicate Management Ltd.
EOS Syndicate Management Ltd. Investment ManagersFinance EOS Syndicate Management invests in companies located in United Kingdom. The firm targets companies operating in science, engineering and technology sector. It provides financing for seed and growth stage capital requirements with an investment size ranging from EUR 0.1 - 1 millions. It also makes co-investment. | Finance |
Chromacity Ltd.
Chromacity Ltd. Medical SpecialtiesHealth Technology Designs, manufactures and supplies ultrafast fibre lasers | Health Technology |
Cumulus Oncology Ltd.
Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Develops oncology drugs | Health Technology |
Dxcover Ltd.
Dxcover Ltd. Medical SpecialtiesHealth Technology Manufactures hardware and develops artificial intelligence based software for early detection of cancers | Health Technology |
















